论文部分内容阅读
1969年啦丙秦（oxaProzin）首次取得专利权。80年代初由WyethLabora切nes开始进行开发，本评介中引用的许多研究与该时期有关。1988年该公司把本品许可给GDSearle＆ComPanyf后者向FDA提出批准申请并预期本品于1992年上市“。本品获FDA批准后专利期可延长5年。本品的化学名为4，
In 1969, oxaProzin was patented for the first time. Development started in the early 1980s by Wyeth Labora nes, and many of the studies cited in this review relate to this period. The company licensed the product to GDSearle & ComPanyf in 1988 and the FDA submitted the FDA’s approval of the application and expected the product was launched in 1992. "This product is approved by the FDA after the extension of the patent period of 5 years. The chemical name of this product is 4,